|
1
|
Wallenstein GV, Kanik KS, Wilkinson B,
Cohen S, Cutolo M, Fleishmann R, Genovese MC, Gomez Reino J, Gruben
D, Kremer J, et al: Effects of the oral Janus kinase inhibitor
tofacitinib on patient-reported outcomes in patients with active
rheumatoid arthritis: Results of two phase 2 randomised controlled
trials. Clin Exp Rheumatol. 34:430–442. 2016.PubMed/NCBI
|
|
2
|
Izumi K, Kaneko Y, Hashizume M, Yoshimoto
K and Takeuchi T: Baseline serum osteopontin levels predict the
clinical effectiveness of tocilizumab but not infliximab in
biologic-naïve patients with rheumatoid arthritis: A single-center
prospective study at 1 year (the Keio First-Bio Cohort study). PLoS
One. 10:e01454682015. View Article : Google Scholar
|
|
3
|
Xu Y, Zhu Q, Song J, Liu H, Miao Y, Yang
F, Wang F, Cheng W, Xi Y, Niu X, et al: Regulatory effect of
iguratimod on the balance of Th subsets and inhibition of
inflammatory cytokines in patients with rheumatoid arthritis.
Mediators Inflamm. 2015:3560402015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Durez P, Vandepapeliere P, Miranda P,
Toncheva A, Berman A, Kehler T, Mociran E, Fautrel B, Mariette X,
Dhellin O, et al: Therapeutic vaccination with TNF-Kinoid in TNF
antagonist- resistant rheumatoid arthritis: A phase II randomized,
controlled clinical trial. PLoS One. 9:e1134652014. View Article : Google Scholar
|
|
5
|
Genovese MC, Kremer J, Zamani O, Ludivico
C, Krogulec M, Xie L, Beattie SD, Koch AE, Cardillo TE, Rooney TP,
et al: Baricitinib in patients with refractory rheumatoid
arthritis. N Engl J Med. 374:1243–1252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maeda Y, Farina NH, Matzelle MM, Fanning
PJ, Lian JB and Gravallese EM: Synovium-derived microRNAs regulate
bone pathways in rheumatoid arthritis. J Bone Miner Res.
32:461–472. 2017. View Article : Google Scholar :
|
|
7
|
Krintel SB, Dehlendorff C, Hetland ML,
Hørslev-Petersen K, Andersen KK, Junker P, Pødenphant J, Ellingsen
T, Ahlquist P, Lindegaard HM, et al: Prediction of treatment
response to adalimumab: A double-blind placebo-controlled study of
circulating microRNA in patients with early rheumatoid arthritis.
Pharmacogenomics J. 16:141–146. 2016. View Article : Google Scholar
|
|
8
|
Abou-Zeid A, Saad M and Soliman E:
MicroRNA 146a expression in rheumatoid arthritis: Association with
tumor necrosis factor-alpha and disease activity. Genet Test Mol
Biomarkers. 15:807–812. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang G, Wu D, Zeng G, Jiang O, Yuan P,
Huang S, Zhu J, Tian J, Weng Y and Rao Z: Correlation between
miR-126 expression and DNA hypomethylation of CD4+ T
cells in rheumatoid arthritis patients. Int J Clin Exp Pathol.
8:8929–8936. 2015.
|
|
10
|
Jiang Y and Wang L: Role of histone
deacetylase 3 in ankylosing spondylitis via negative feedback loop
with microRNA-130a and enhancement of tumor necrosis factor-1α
expression in peripheral blood mononuclear cells. Mol Med Rep.
13:35–40. 2016. View Article : Google Scholar
|
|
11
|
Li ZC, Han N, Li X, Li G, Liu YZ, Sun GX,
Wang Y, Chen GT and Li GF: Decreased expression of microRNA-130a
correlates with TNF-α in the development of osteoarthritis. Int J
Clin Exp Pathol. 8:2555–2564. 2015.
|
|
12
|
Kuuliala K, Kuuliala A, Hämäläinen M,
Koivuniemi R, Kautiainen H, Moilanen E, Repo H and Leirisalo-Repo
M: Impaired Akt phosphorylation in monocytes of patients with
rheumatoid arthritis. Scand J Immunol. 85:155–161. 2017. View Article : Google Scholar
|
|
13
|
Zhang W, Du Z, Zhu J, Yu J and Xu Y:
Sprouty2 suppresses the inflammatory responses in rheumatoid
arthritis fibroblast-like synoviocytes through regulating the
Raf/ERK and PTEN/AKT signals. Mol Immunol. 67:532–539. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang CR, Shiau AL, Chen SY, Lin LL, Tai
MH, Shieh GS, Lin PR, Yo YT, Lee CH, Kuo SM, et al: Amelioration of
collagen-induced arthritis in rats by adenovirus-mediated PTEN gene
transfer. Arthritis Rheum. 58:1650–1656. 2008. View Article : Google Scholar
|
|
15
|
Malemud CJ: The PI3K/Akt/PTEN/mTOR
pathway: A fruitful target for inducing cell death in rheumatoid
arthritis? Future Med Chem. 7:1137–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Østergaard M, Jacobsson LT, Schaufelberger
C, Hansen MS, Bijlsma JW, Dudek A, Rell-Bakalarska M, Staelens F,
Haake R, Sundman-Engberg B, et al: MRI assessment of early response
to certolizumab pegol in rheumatoid arthritis: A randomised,
double-blind, placebo-controlled phase IIIb study applying MRI at
weeks 0, 1, 2, 4, 8 and 16. Ann Rheum Dis. 74:1156–1163. 2015.
View Article : Google Scholar :
|
|
17
|
Zhu Q, Huang J, Wang SZ, Qin ZH and Lin F:
Cobrotoxin extracted from Naja atra venom relieves arthritis
symptoms through anti-inflammation and immunosuppression effects in
rat arthritis model. J Ethnopharmacol. 194:1087–1095. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McWilliams DF, Ferguson E, Young A, Kiely
PD and Walsh DA: Discordant inflammation and pain in early and
established rheumatoid arthritis: Latent Class Analysis of Early
Rheumatoid Arthritis Network and British Society for Rheumatology
Biologics Register data. Arthritis Res Ther. 18:2952016. View Article : Google Scholar :
|
|
19
|
Zumbrennen-Bullough KB, Wu Q, Core AB,
Canali S, Chen W, Theurl I, Meynard D and Babitt JL: MicroRNA-130a
is up-regulated in mouse liver by iron deficiency and targets the
bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP
signaling and hepcidin transcription. J Biol Chem. 289:23796–23808.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jia Q, Cheng W, Yue Y, Hu Y, Zhang J, Pan
X, Xu Z and Zhang P: Cucurbitacin E inhibits TNF-α-induced
inflammatory cytokine production in human synoviocyte MH7A cells
via suppression of PI3K/Akt/NF-κB pathways. Int Immunopharmacol.
29:884–890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang TT, Song Y, Ding YJ, Liao YH, Yu X,
Du R, Xiao H, Yuan J, Zhou ZH, Liao MY, et al: Atorvastatin
upregulates regulatory T cells and reduces clinical disease
activity in patients with rheumatoid arthritis. J Lipid Res.
52:1023–1032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao J, Zhou XL, Kong RN, Ji LM, He LL and
Zhao DB: microRNA-126 targeting PIK3R2 promotes rheumatoid
arthritis synovial fibro-blasts proliferation and resistance to
apoptosis by regulating PI3K/AKT pathway. Exp Mol Pathol.
100:192–198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu X, Song Y, Huo R, Zhang J, Sun S, He
Y, Gao H, Zhang M, Sun X, Zhai T, et al: Cyr61 participates in the
pathogenesis of rheumatoid arthritis by promoting proIL-1β
production by fibroblast-like synoviocytes through an AKT-dependent
NF-κB signaling pathway. Clin Immunol. 157:187–197. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu C, Wang X, Ha T, Hu Y, Liu L, Zhang X,
Yu H, Miao J, Kao R, Kalbfleisch J, et al: Attenuation of cardiac
dysfunction and remodeling of myocardial infarction by
microRNA-130a are mediated by suppression of PTEN and activation of
PI3K dependent signaling. J Mol Cell Cardiol. 89:87–97. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee SH, Park JS, Byun JK, Jhun J, Jung K,
Seo HB, Moon YM, Kim HY, Park SH and Cho ML: PTEN ameliorates
autoimmune arthritis through down-regulating STAT3 activation with
reciprocal balance of Th17 and Tregs. Sci Rep. 6:346172016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song CL, Liu B, Shi YF, Liu N, Yan YY,
Zhang JC, Xue X, Wang JP, Zhao Z, Liu JG, et al: MicroRNA-130a
alleviates human coronary artery endothelial cell injury and
inflammatory responses by targeting PTEN via activating
PI3K/Akt/eNOS signaling pathway. Oncotarget. 7:71922–71936. 2016.
View Article : Google Scholar : PubMed/NCBI
|
